| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.698 | 35.860 | 35.099 | 34.283 | 29.942 | 39.449 | 44.429 | 44.738 | 13.697 | 787 |
| Total Income - EUR | 2.698 | 35.860 | 35.099 | 34.507 | 30.481 | 40.069 | 45.820 | 44.741 | 13.697 | 787 |
| Total Expenses - EUR | 636 | 11.964 | 9.803 | 7.410 | 7.460 | 7.869 | 8.805 | 9.766 | 5.755 | 1.536 |
| Gross Profit/Loss - EUR | 2.062 | 23.896 | 25.296 | 27.097 | 23.022 | 32.199 | 37.015 | 34.975 | 7.942 | -749 |
| Net Profit/Loss - EUR | 1.981 | 23.179 | 24.771 | 26.068 | 22.165 | 31.318 | 35.975 | 34.085 | 7.815 | -749 |
| Employees | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Calistomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 198 | 623 | 1.241 | 1.620 | 2.193 | 3.220 | 1.178 | 409 | 639 | 319 |
| Current Assets | 2.809 | 23.255 | 23.909 | 30.341 | 45.914 | 65.159 | 35.996 | 33.991 | 12.054 | 7.333 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 |
| Receivables | 2.698 | 6.266 | 14.554 | 17.732 | 36.239 | 45.435 | 33.960 | 30.966 | 10.086 | 5.252 |
| Cash | 112 | 16.989 | 9.355 | 12.609 | 9.674 | 19.720 | 2.032 | 3.021 | 1.964 | 2.077 |
| Shareholders Funds | 2.094 | 23.358 | 24.889 | 26.184 | 47.842 | 66.676 | 36.084 | 34.194 | 12.693 | 7.652 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 914 | 520 | 261 | 5.776 | 264 | 281 | 1.090 | 206 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 1.422 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Calistomed Srl